Compensated cirrhosis: an aerobic exercise trial shows a benefit in walking capacity

Can aerobic exercise improve physical fitness without worsening the circulatory disturbances associated with cirrhosis? A randomized trial in 50 sedentary patients with compensated cirrhosis reports improved walking capacity after 16 weeks. However, most autonomic and vascular measurements show no statistically significant difference between groups. Only the abstract was consulted.

Illustration of walking and the physical capacity measures studied in people with compensated cirrhosis.
TrainingEditorial illustration, not study data.

An exercise program compared with nutritional counseling alone

The researchers assigned participants to two groups of 25 people. The first followed a moderate-intensity aerobic exercise program combined with nutritional counseling. The second received nutritional counseling alone. The mean age was 62.6 years, and 60% of participants were women.

Of the 50 people enrolled, 44 completed the study. Assessments covered heart rate variability, peripheral blood vessel dilation, abdominal blood flow and several physical measures: body composition, grip strength and distance covered in the six-minute walk test.

A functional result more convincing than the circulatory signals

The result most directly relevant to physical fitness concerns the six-minute walk test, which improved significantly in the exercise group compared with the control group. This test measures functional capacity. On its own, it does not demonstrate a reduction in cirrhosis complications or mortality.

For most other outcomes, no statistically significant difference was found between groups. An increase in portal vein blood flow was observed within the exercise group in one analysis, but a change within a single group is not enough to demonstrate an effect greater than that of the comparator.

The abstract also reports a signal relating to autonomic regulation of the heart. However, the way it is presented does not allow a clear clinical conclusion, and the authors call for cautious interpretation of the autonomic and hepatic findings.

Reassuring tolerability, within a limited setting

No major adverse events were reported during the trial. This observation is reassuring for the patients studied, but 50 participants followed for 16 weeks cannot rule out rare risks or support conclusions about decompensated cirrhosis.

This study mainly supports the potential value of adapted exercise for physical capacity in compensated cirrhosis. The available abstract does not provide the details needed to reproduce the program. If this applies to you, putting it into practice calls for medical advice rather than an improvised protocol.

Limitations to keep in mind

A small trial limited to compensated cirrhosis, with 16 weeks of follow-up and several analytical approaches reported. The dossier contains only the abstract, not the full text. Program details, funding and conflicts of interest could not be verified.

What we can take away

The clearest benefit concerns walking capacity, not a demonstrated improvement in liver disease. The circulatory signals remain exploratory.

Sources and provenance

Partager cet article

X f in

An error or a source to report? Contact the editorial team.